Corporate Sponsors

Bio-Rad

Proteintech

SULSA Bulletin

To see the latest SULSA bulletin click here.

SULSA Chemistry Catalyst Fund

The most recent call for applications closed on

1 April 2011. 

Applications are not being accepted at the moment.

Researchers at SULSA universities can apply for up to £20,000 SULSA funding to cover proof of concept medicinal chemistry projects. The goal of the fund is to fill the funding gap between hits from a screen into validated leads. The most recent deadline for applications was 1 April 2011, so this call for applications is now closed.

In Scope:

  • Initial optimisation of hits or fragments from screening projects where additional chemistry SAR will strengthen a follow-on grant application (for example, the results of a SULSA funded HTS project).
  • Medicinal Chemistry projects where a limited, specific synthetic chemistry programme could justifiably generate preliminary results for a grant application.
  • Drug Metabolism and pharmacokinetic analysis to aid translational grant applications.
Out of Scope:
  • Synthesis of existing tool compounds, assay standards or literature compounds.
  • Primary biological screening and assays.
The call is open to all principal investigators in SULSA Institutions. The choice of facility or laboratory for undertaking the project is at the discretion of the applicant, but chemistry design and synthesis expertise is available at a number of SULSA institutions including the Drug Discovery Unit at the University of Dundee and Strathclyde Institute of Pharmacy and Biomedical Sciences, at the University of Strathclyde, the Chemistry/Biology Interface at EaStChem and the Synthetic and Biological Chemistry Theme at WestChem.
 
Drug metabolism and pharmacokinetic expertise is available at the Drug Discovery Unit at the University of Dundee.
 
All proposals should show a contribution of matching funds at a minimum level of 10%. 
 
For further information, please contact the SULSA Translational Biology Theme Administrator
 
Janette Moore.
Phone: +44 (0) 1382 384232
 
The most recent call for applications is now closed.

Back to top

Latest News

Proteintech gains recognition for consistently meeting customer needs

Wed, 16/05/2012 - 14:50

SULSA Corporate Partner Proteintech Europe are pleased to announce that they have been awarded...

More

SULSA Student Hollie Vase presents at Experimental Biology 2012

Thu, 10/05/2012 - 15:51

SULSA Student Hollie Vase (University of Aberdeen) had 2 abstracts accepted for the Experiment...

More

University of Dundee voted best student experience in the UK

Thu, 26/04/2012 - 09:44

SULSA Congratulates the University of Dundee for being voted as having the best student experience...

More

SULSA Participates in Gen2Bio 2012

Tue, 24/04/2012 - 16:02

Gen2Bio is the annual congress organised by Biogenouest, the life science and environment technology...

More

Professor Andrew Millar elected to Royal Society

Tue, 24/04/2012 - 15:57

Professor Andrew Millar has been elected to the Fellowship of the Royal Society. Andrew is Professor...

More

SULSA Young Scientists Meeting 2012 - Shout About Science!

Mon, 26/03/2012 - 12:23

Building on the success from last years SULSA Young Scientist Event, SULSA organised the 2012 YSE....

More

Proteintech and SULSA begin search for Scottish Antibody Champion

Mon, 26/03/2012 - 12:05

Beginning this month, International Biotechnology Company Proteintech has teamed up with the...

More

Call for Proposals – SULSA is providing funding to support Postdoctoral and Early Career Researcher Exchanges with Europe, USA, Canada, China and India.

Fri, 23/03/2012 - 13:09

The purpose of this new SULSA funding is to provide research training and development opportunities...

More

SULSA Student Eduard Kerkhoven publishes on the metabolism of Trypanosoma brucei

Fri, 16/03/2012 - 11:40

SULSA Student Eduard Kerkhoven has published along with SULSA Professor Rainer Breitling (University...

More

Target Development Fund Call for Proposals

Mon, 12/03/2012 - 09:43

Target Development Fund seeks proposals for the translation of novel drug targets or leads...

More

BioSKAPE

BioSKAPE Logo